Establishment and application of a multiplex genetic mutation-detection method of lung cancer based on MassARRAY platform.

作者: Shi-Liang Chen , Hong-Xia Tian , Xu-Chao Zhang , Wei-Bang Guo , Jian-Guang Chen

DOI: 10.28092/J.ISSN.2095-3941.2015.0094

关键词:

摘要: Objective: This study aims to establish a method for highly parallel multiplexed detection of genetic mutations in Chinese lung cancer samples through Agena iPLEX chemistry and matrix-assisted laser desorption ionization time-of-flight analysis on MassARRAY mass spectrometry platform. Methods: We reviewed the related literature data treatments. also identified 99 mutation hot spots 13 target genes closely pathogenesis, drug resistance, metastasis cancer. A total 297 primers, composed paired forward reverse amplification primers matched extension were designed using Assay Design software. The was established by analyzing eight cell lines six specimens. proposed then validated comparisons LungCartaTM kit. sensitivity specificity evaluated directly sequencing EGFR KRAS 100 cases. Results: able detect multiplex lines. finding consistent with observations previously reported mutations. can such clinical result However, an FGFR2 detected only method. measured 100% 96.3%, respectively. Conclusions: technology-based patients. Therefore, be applied other tissues.

参考文章(25)
Isamu Okamoto, Kazuko Sakai, Satoshi Morita, Hiroshige Yoshioka, Hiroyasu Kaneda, Koji Takeda, Tomonori Hirashima, Yoshihito Kogure, Tatsuo Kimura, Toshiaki Takahashi, Shinji Atagi, Takashi Seto, Toshiyuki Sawa, Masashi Yamamoto, Miyako Satouchi, Motoyasu Okuno, Seisuke Nagase, Koichi Takayama, Keisuke Tomii, Tadashi Maeda, Satoshi Oizumi, Shinji Fujii, Yusaku Akashi, Kazumi Nishino, Noriyuki Ebi, Kazuhiko Nakagawa, Yoichi Nakanishi, Kazuto Nishio, Multiplex genomic profiling of non–small cell lung cancers from the LETS phase III trial of first-line S-1/carboplatin versus paclitaxel/carboplatin: results of a West Japan Oncology Group study Oncotarget. ,vol. 5, pp. 2293- 2304 ,(2014) , 10.18632/ONCOTARGET.1906
Mark Kriegsmann, Norbert Arens, Volker Endris, Wilko Weichert, Jörg Kriegsmann, Detection of KRAS, NRAS and BRAF by mass spectrometry - a sensitive, reliable, fast and cost-effective technique Diagnostic Pathology. ,vol. 10, pp. 132- 132 ,(2015) , 10.1186/S13000-015-0364-3
She-Juan An, Zhi-Hong Chen, Jian Su, Xu-Chao Zhang, Wen-Zhao Zhong, Jin-Ji Yang, Qing Zhou, Xue-Ning Yang, Ling Huang, Ji-Lin Guan, Qiang Nie, Hong-Hong Yan, Tony S. Mok, Yi-Long Wu, Identification of Enriched Driver Gene Alterations in Subgroups of Non-Small Cell Lung Cancer Patients Based on Histology and Smoking Status PLoS ONE. ,vol. 7, pp. e40109- ,(2012) , 10.1371/JOURNAL.PONE.0040109
Jian Su, Xu-Chao Zhang, She-Juan An, Wen-Zhao Zhong, Ying Huang, Shi-Liang Chen, Hong-Hong Yan, Zhi-Hong Chen, Wei-Bang Guo, Xiao-Sui Huang, Yi-Long Wu, Detecting the spectrum of multiplex gene mutations in non-small cell lung cancer by Snapshot assay Chinese Journal of Cancer. ,vol. 33, pp. 346- 350 ,(2014) , 10.5732/CJC.013.10195
Kwun M Fong, John D Minna, Molecular Biology of Lung Cancer: Clinical Implications Clinics in Chest Medicine. ,vol. 23, pp. 83- 101 ,(2002) , 10.1016/S0272-5231(03)00062-5
Anne Marie Quinn, Nicholas Hickson, Megan Adaway, Lynsey Priest, Erich Jaeger, Nitin Udar, Catherine Keeling, Martyna Kamieniorz, Caroline Dive, Andrew Wallace, Richard J. Byers, William G. Newman, Daisuke Nonaka, Fiona H. Blackhall, Diagnostic mutation profiling and validation of non small cell lung cancer small biopsy samples using a high throughput platform. Journal of Thoracic Oncology. ,vol. 10, pp. 784- 792 ,(2015) , 10.1097/JTO.0000000000000473
Aaron M Newman, Scott V Bratman, Jacqueline To, Jacob F Wynne, Neville C W Eclov, Leslie A Modlin, Chih Long Liu, Joel W Neal, Heather A Wakelee, Robert E Merritt, Joseph B Shrager, Billy W Loo, Ash A Alizadeh, Maximilian Diehn, An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage Nature Medicine. ,vol. 20, pp. 548- 554 ,(2014) , 10.1038/NM.3519
Weimin Gao, Hussam H. Mady, Mona F. Melhem, Phouthone Keohavong, Analysis of p53 mutations in histologically normal lung tissues and lung tumors from non-small cell lung cancer patients. Molecular Carcinogenesis. ,vol. 48, pp. 633- 641 ,(2009) , 10.1002/MC.20505
Young Lim Choi, Manabu Soda, Yoshihiro Yamashita, Toshihide Ueno, Junpei Takashima, Takahiro Nakajima, Yasushi Yatabe, Kengo Takeuchi, Toru Hamada, Hidenori Haruta, Yuichi Ishikawa, Hideki Kimura, Tetsuya Mitsudomi, Yoshiro Tanio, Hiroyuki Mano, EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors The New England Journal of Medicine. ,vol. 363, pp. 1734- 1739 ,(2010) , 10.1056/NEJMOA1007478
Johannes M. Heuckmann, Michael Hölzel, Martin L. Sos, Stefanie Heynck, Hyatt Balke-Want, Mirjam Koker, Martin Peifer, Jonathan Weiss, Christine M. Lovly, Christian Grütter, Daniel Rauh, William Pao, Roman K. Thomas, ALK Mutations Conferring Differential Resistance to Structurally Diverse ALK Inhibitors Clinical Cancer Research. ,vol. 17, pp. 7394- 7401 ,(2011) , 10.1158/1078-0432.CCR-11-1648